BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 21979959)

  • 1. EphrinA1-EphA2 signal induces compaction and polarization of Madin-Darby canine kidney cells by inactivating Ezrin through negative regulation of RhoA.
    Wakayama Y; Miura K; Sabe H; Mochizuki N
    J Biol Chem; 2011 Dec; 286(51):44243-44253. PubMed ID: 21979959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Redox regulation of ephrin/integrin cross-talk.
    Buricchi F; Giannoni E; Grimaldi G; Parri M; Raugei G; Ramponi G; Chiarugi P
    Cell Adh Migr; 2007; 1(1):33-42. PubMed ID: 19262085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Expression of ephrinA1/ephA2 Receptor Increases in Chronic Rhinosinusitis and ephrinA1/ephA2 Signaling Affects Rhinovirus-Induced Innate Immunity in Human Sinonasal Epithelial Cells.
    Lee SH; Kang SH; Han MS; Kwak JW; Kim HG; Lee TH; Lee DB; Kim TH
    Front Immunol; 2021; 12():793517. PubMed ID: 34975898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EphA kinase activation regulates HGF-induced epithelial branching morphogenesis.
    Miao H; Nickel CH; Cantley LG; Bruggeman LA; Bennardo LN; Wang B
    J Cell Biol; 2003 Sep; 162(7):1281-92. PubMed ID: 14517207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EphrinA1-induced cytoskeletal re-organization requires FAK and p130(cas).
    Carter N; Nakamoto T; Hirai H; Hunter T
    Nat Cell Biol; 2002 Aug; 4(8):565-73. PubMed ID: 12134157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer-associated fibroblasts promote gastric tumorigenesis through EphA2 activation in a ligand-independent manner.
    Hong HN; Won YJ; Shim JH; Kim HJ; Han SH; Kim BS; Kim HS
    J Cancer Res Clin Oncol; 2018 Sep; 144(9):1649-1663. PubMed ID: 29948146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EphrinA1 inactivates integrin-mediated vascular smooth muscle cell spreading via the Rac/PAK pathway.
    Deroanne C; Vouret-Craviari V; Wang B; Pouysségur J
    J Cell Sci; 2003 Apr; 116(Pt 7):1367-76. PubMed ID: 12615978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of erythropoietin-producing hepatocellular receptor A2 attenuates cell adhesion of human fallopian tube epithelial cells via focal adhesion kinase dephosphorylation.
    Yang XY; Zhu WJ; Jiang H
    Mol Cell Biochem; 2012 Feb; 361(1-2):259-65. PubMed ID: 22009484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bidirectional signalling between EphA2 and ephrinA1 increases tubular cell attachment, laminin secretion and modulates erythropoietin expression after renal hypoxic injury.
    Rodriguez S; Rudloff S; Koenig KF; Karthik S; Hoogewijs D; Huynh-Do U
    Pflugers Arch; 2016 Aug; 468(8):1433-48. PubMed ID: 27228995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EphA2 as a novel molecular marker and target in glioblastoma multiforme.
    Wykosky J; Gibo DM; Stanton C; Debinski W
    Mol Cancer Res; 2005 Oct; 3(10):541-51. PubMed ID: 16254188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spatially modulated ephrinA1:EphA2 signaling increases local contractility and global focal adhesion dynamics to promote cell motility.
    Chen Z; Oh D; Biswas KH; Yu CH; Zaidel-Bar R; Groves JT
    Proc Natl Acad Sci U S A; 2018 Jun; 115(25):E5696-E5705. PubMed ID: 29866846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EphrinA1 activates a Src/focal adhesion kinase-mediated motility response leading to rho-dependent actino/myosin contractility.
    Parri M; Buricchi F; Giannoni E; Grimaldi G; Mello T; Raugei G; Ramponi G; Chiarugi P
    J Biol Chem; 2007 Jul; 282(27):19619-28. PubMed ID: 17449913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EphA2 engages Git1 to suppress Arf6 activity modulating epithelial cell-cell contacts.
    Miura K; Nam JM; Kojima C; Mochizuki N; Sabe H
    Mol Biol Cell; 2009 Apr; 20(7):1949-59. PubMed ID: 19193766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EphrinA1 repulsive response is regulated by an EphA2 tyrosine phosphatase.
    Parri M; Buricchi F; Taddei ML; Giannoni E; Raugei G; Ramponi G; Chiarugi P
    J Biol Chem; 2005 Oct; 280(40):34008-18. PubMed ID: 16051609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble monomeric EphrinA1 is released from tumor cells and is a functional ligand for the EphA2 receptor.
    Wykosky J; Palma E; Gibo DM; Ringler S; Turner CP; Debinski W
    Oncogene; 2008 Dec; 27(58):7260-73. PubMed ID: 18794797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EphrinA1-EphA2 interaction-mediated apoptosis and FMS-like tyrosine kinase 3 receptor ligand-induced immunotherapy inhibit tumor growth in a breast cancer mouse model.
    Tandon M; Vemula SV; Sharma A; Ahi YS; Mittal S; Bangari DS; Mittal SK
    J Gene Med; 2012 Feb; 14(2):77-89. PubMed ID: 22228563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tobacco smoke induces epithelial barrier dysfunction via receptor EphA2 signaling.
    Nasreen N; Khodayari N; Sriram PS; Patel J; Mohammed KA
    Am J Physiol Cell Physiol; 2014 Jun; 306(12):C1154-66. PubMed ID: 24717580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulation of EphA2 and down-regulation of EphrinA1 are associated with the aggressive phenotype and poor prognosis of malignant glioma.
    Li X; Wang L; Gu JW; Li B; Liu WP; Wang YG; Zhang X; Zhen HN; Fei Z
    Tumour Biol; 2010 Oct; 31(5):477-88. PubMed ID: 20571968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Na+/H+ exchanger regulatory factor 1 overexpression-dependent increase of cytoskeleton organization is fundamental in the rescue of F508del cystic fibrosis transmembrane conductance regulator in human airway CFBE41o- cells.
    Favia M; Guerra L; Fanelli T; Cardone RA; Monterisi S; Di Sole F; Castellani S; Chen M; Seidler U; Reshkin SJ; Conese M; Casavola V
    Mol Biol Cell; 2010 Jan; 21(1):73-86. PubMed ID: 19889841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EphrinA1 inhibits vascular endothelial growth factor-induced intracellular signaling and suppresses retinal neovascularization and blood-retinal barrier breakdown.
    Ojima T; Takagi H; Suzuma K; Oh H; Suzuma I; Ohashi H; Watanabe D; Suganami E; Murakami T; Kurimoto M; Honda Y; Yoshimura N
    Am J Pathol; 2006 Jan; 168(1):331-9. PubMed ID: 16400034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.